SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001157523-08-002294
Filing Date
2008-03-18
Accepted
2008-03-18 12:14:37
Documents
6
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 OPEXA THERAPEUTICS, INC. 10-K a5635058.htm 10-K 1808810
2 EXHIBIT 31.1 a5635058ex31_1.htm EX-31.1 16036
3 EXHIBIT 31.2 a5635058ex31_2.htm EX-31.2 16072
4 EXHIBIT 32.1 a5635058ex32_1.htm EX-32.1 6499
5 EXHIBIT 32.2 a5635058ex32_2.htm EX-32.2 6556
6 GRAPHIC logo.jpg GRAPHIC 2383
  Complete submission text file 0001157523-08-002294.txt   1859104
Mailing Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381
Business Address 2635 N. CRESCENT RIDGE DRIVE THE WOODLANDS TX 77381 (281) 272-9331
Opexa Therapeutics, Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33004 | Film No.: 08695504
SIC: 2834 Pharmaceutical Preparations